BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34411579)

  • 1. A pan-cancer study of spalt-like transcription factors 1/2/3/4 as therapeutic targets.
    Ma T; Shi S; Jiang H; Chen X; Xu D; Ding X; Zhang H; Xi Y
    Arch Biochem Biophys; 2021 Oct; 711():109016. PubMed ID: 34411579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SALL Proteins; Common and Antagonistic Roles in Cancer.
    Álvarez C; Quiroz A; Benítez-Riquelme D; Riffo E; Castro AF; Pincheira R
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sall1, sall2, and sall4 are required for neural tube closure in mice.
    Böhm J; Buck A; Borozdin W; Mannan AU; Matysiak-Scholze U; Adham I; Schulz-Schaeffer W; Floss T; Wurst W; Kohlhase J; Barrionuevo F
    Am J Pathol; 2008 Nov; 173(5):1455-63. PubMed ID: 18818376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pan-Cancer Analysis of the BIRC Gene Family and Its Association with Prognosis, Tumor Microenvironment, and Therapeutic Targets.
    Wu S; Zang Q; Xing Z; Li X; Leng J; Liu Y; Wang X; Yang J
    Crit Rev Eukaryot Gene Expr; 2021; 31(4):35-48. PubMed ID: 34587434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pan-cancer study of class-3 semaphorins as therapeutic targets in cancer.
    Zhang X; Klamer B; Li J; Fernandez S; Li L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):45. PubMed ID: 32241267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sal-like 4 protein levels in breast cancer cells are post-translationally down-regulated by tripartite motif-containing 21.
    Itou J; Li W; Ito S; Tanaka S; Matsumoto Y; Sato F; Toi M
    J Biol Chem; 2018 Apr; 293(17):6556-6564. PubMed ID: 29511085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc finger protein sall2 is not essential for embryonic and kidney development.
    Sato A; Matsumoto Y; Koide U; Kataoka Y; Yoshida N; Yokota T; Asashima M; Nishinakamura R
    Mol Cell Biol; 2003 Jan; 23(1):62-9. PubMed ID: 12482961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel SALL4/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells.
    Yang J; Gao C; Chai L; Ma Y
    PLoS One; 2010 May; 5(5):e10766. PubMed ID: 20505821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pan-Cancer Study of Epidermal Growth Factor-Like Domains 6/7/8 as Therapeutic Targets in Cancer.
    Shi S; Ma T; Xi Y
    Front Genet; 2020; 11():598743. PubMed ID: 33391349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental SALL2 transcription factor: a new player in cancer.
    Hermosilla VE; Hepp MI; Escobar D; Farkas C; Riffo EN; Castro AF; Pincheira R
    Carcinogenesis; 2017 Jul; 38(7):680-690. PubMed ID: 28430874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural studies of SALL family protein zinc finger cluster domains in complex with DNA reveal preferential binding to an AATA tetranucleotide motif.
    Ru W; Koga T; Wang X; Guo Q; Gearhart MD; Zhao S; Murphy M; Kawakami H; Corcoran D; Zhang J; Zhu Z; Yao X; Kawakami Y; Xu C
    J Biol Chem; 2022 Dec; 298(12):102607. PubMed ID: 36257403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance.
    Sun B; Xu L; Bi W; Ou WB
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sall genes regulate region-specific morphogenesis in the mouse limb by modulating Hox activities.
    Kawakami Y; Uchiyama Y; Rodriguez Esteban C; Inenaga T; Koyano-Nakagawa N; Kawakami H; Marti M; Kmita M; Monaghan-Nichols P; Nishinakamura R; Izpisua Belmonte JC
    Development; 2009 Feb; 136(4):585-94. PubMed ID: 19168674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pan-cancer analysis of the HER family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
    Yang X; Miao Y; Wang J; Mi D
    Life Sci; 2021 May; 273():119307. PubMed ID: 33691171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types.
    Chang WH; Lai AG
    BMC Cancer; 2020 Aug; 20(1):773. PubMed ID: 32807122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
    Wu HK; Liu C; Fan XX; Wang H; Zhou L
    Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Bulk RNA Sequencing Data Reveals Novel Transcription Factors Associated With Immune Infiltration Among Multiple Cancers.
    Liu L; Zhao Q; Cheng C; Yi J; Sun H; Wang Q; Quan W; Xue Y; Sun L; Cong X; Zhang Y
    Front Immunol; 2021; 12():644350. PubMed ID: 34489925
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Imai A; Mochizuki D; Misawa Y; Nakagawa T; Endo S; Mima M; Yamada S; Kawasaki H; Kanazawa T; Misawa K
    DNA Cell Biol; 2019 Jul; 38(7):678-687. PubMed ID: 31188017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4.
    Chang S; Sun G; Zhang D; Li Q; Qian H
    Cell Death Dis; 2020 Jul; 11(7):592. PubMed ID: 32719361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated pan-cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity.
    Liu JN; Kong XS; Sun P; Wang R; Li W; Chen QF
    J Cell Mol Med; 2021 Feb; 25(4):2082-2097. PubMed ID: 33373169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.